US2003172411A1PendingUtilityA1
Disease resistance factors
Priority: Nov 5, 1998Filed: May 4, 2001Published: Sep 11, 2003
Est. expiryNov 5, 2018(expired)· nominal 20-yr term from priority
Inventors:Karlene H. ButlerSaverio Carl FalcoOmolayo O. FamoduYiwen FangFeng HanElmer P. HeppardZhan-Bin LiuJoan T. OdellJ. RafalskiGuo-Hua Miao
C12N 15/8209C12N 9/0004C12N 15/8279C07K 14/415
49
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
This invention relates to isolated nucleic acid fragments encoding corn ( Zea mays ), rice ( Oryza sativa ), or wheat ( Triticum aestivum ) NPR1 homologs. The invention also relates to the construction of a chimeric gene encoding all or a portion of the NPR1 homolog, in sense or antisense orientation, wherein expression of the chimeric gene results in production of altered levels of the NPR1 homolog in a transformed host cell.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . An isolated polynucleotide that encodes an NPR1 polypeptide having a sequence identity of at least 80% based on the Clustal method of alignment when compared to a polypeptide selected from the group consisting of SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, and 16.
2 . The polynucleotide of claim 1 wherein the sequence identity is at least 85%.
3 . The polynucleotide of claim 1 wherein the sequence identity is at least 90%.
4 . The polynucleotide of claim 1 wherein the sequence identity is at least 95%.
5 . The polynucleotide of claim 1 wherein the polynucleotide encodes a polypeptide selected from the group consisting of SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, and 16.
6 . The polynucleotide of claim 1 wherein the polynucleotide comprises a nucleotide sequence selected from the group consisting of SEQ ID NO: 1, 3, 5, 7, 9, 11, 13, and 15.
7 . The polynucleotide of claim 1 wherein the polypeptide is an NPR1.
8 . An isolated complement of the polynucleotide of claim 1 , wherein
(a) the complement and the polynucleotide consist of the same number of nucleotides, and (b) the nucleotide sequences of the complement and the polynucleotide have 100% complementarity.
9 . An isolated nucleic acid molecule that (1) comprises at least 100 nucleotides and (2) remains hybridized with the isolated polynucleotide of claim 1 under a wash condition of 0.1×SSC, 0.1% SDS, and 65° C.
10 . A cell comprising the polynucleotide of claim 1 .
11 . The cell of claim 10 , wherein the cell is selected from the group consisting of a yeast cell, a bacterial cell and a plant cell.
12 . A virus comprising the polynucleotide of claim 1 .
13 . A transgenic plant comprising the polynucleotide of claim 1 .
14 . A method for transforming a cell, comprising introducing into a cell the polynucleotide of claim 1 .
15 . A method for producing a transgenic plant comprising
(a) transforming a plant cell with the polynucleotide of claim 1 , and (b) regenerating a plant from the transformed plant cell.
16 . A method for producing a polynucleotide fragment comprising
(a) selecting a nucleotide sequence comprised by the polynucleotide of claim 1 , and (b) synthesizing a polynucleotide fragment containing the nucleotide sequence.
17 . The method of claim 16 , wherein the fragment is produced in vivo.
18 . An isolated NPR1 polypeptide that has a sequence identity of at least 80% based on the Clustal method compared to an amino acid sequence selected from the group consisting of SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, and 16.
19 . The isolated polypeptide of claim 18 wherein the sequence identity is at least 85%.
20 . The isolated polypeptide of claim 18 wherein the sequence identity is at least 90%.
21 . The isolated polypeptide of claim 18 wherein the sequence identity is at least 95%.
22 . The polypeptide of claim 18 wherein the polypeptide has a sequence selected from the group consisting of SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, and 16.
23 . The polypeptide of claim 18 , wherein the polypeptide is aNPR1 .
24 . A chimeric gene comprising the polynucleotide of claim 1 operably linked to at least one regulatory sequence.
25 . A method for altering the level of pathogen resistance in a plant, the method comprising the steps of:
(a) transforming a plant cell with a chimeric gene containing the polypeptide of claim 1; (b) culturing the transformed plant cell under conditions suitable for the expression of the chimeric gene; (c) maintaining the plant cell under conditions that are suitable for its development into a plant; and (d) comparing the level of pathogen resistance of the plant cell containing the polynucleotide of claim 1 and a plant cell not containing the polynucleotide of claim 1.Join the waitlist — get patent alerts
Track US2003172411A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.